Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jarunya, Ngamkham"'
Autor:
Jarunya Ngamkham, Siraprapa Siritutsoontorn, Saowaluk Saisomboon, Kulthida Vaeteewoottacharn, Sarawut Jitrapakdee
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Pyruvate carboxylase (PC) is an important anaplerotic enzyme that replenishes the tricarboxylic acid cycle (TCA) intermediates. It prevents the collapse of the TCA cycle upon its intermediates are removed during high anabolic demand. We have recently
Externí odkaz:
https://doaj.org/article/c4b7274d8fd247a2bffcb46b4bd28374
Autor:
Peerapat Khamwachirapithak, Chanitra Thuwajit, Varodom Charoensawan, Sarawut Jitrapakdee, Kornkamon Lertsuwan, Jarunya Ngamkham, Peti Thuwajit
Publikováno v:
Anticancer Research. 40:6285-6293
Background/aim Pyruvate carboxylase (PC) is a major anaplerotic enzyme for generating oxaloacetate for the TCA cycle and also a key enzyme in gluconeogenesis, de novo fatty acid and amino acid synthesis in normal cells. Recent studies have identified
Publikováno v:
Advances in experimental medicine and biology. 1286
Several studies have exploited the metabolic hallmarks that distinguish between normal and cancer cells, aiming at identifying specific targets of anti-cancer drugs. It has become apparent that metabolic flexibility allows cancer cells to survive dur
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030550349
Several studies have exploited the metabolic hallmarks that distinguish between normal and cancer cells, aiming at identifying specific targets of anti-cancer drugs. It has become apparent that metabolic flexibility allows cancer cells to survive dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a7f84c48b4d9ae40d617239a5058d2
https://doi.org/10.1007/978-3-030-55035-6_2
https://doi.org/10.1007/978-3-030-55035-6_2
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71611 (2013)
Production of matrix metalloproteinases (MMPs) for degradation of extracellular matrix is a vital step in cancer metastasis. We investigated the effects of HPV16 oncoproteins (16E6, 16E6*I and 16E7), either individually or combined, on the transcript
Externí odkaz:
https://doaj.org/article/9196b957b0a743e287e622eb0c0c578d
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1916
We report two protocols to generate human pyruvate carboxylase knockdown and knockout cell lines using short hairpin RNA (shRNA) and CRISPR-Cas9 technologies. The first protocol involved cloning of a shRNA cassette targeted to human pyruvate carboxyl
Publikováno v:
Methods in Molecular Biology ISBN: 9781493989935
We report two protocols to generate human pyruvate carboxylase knockdown and knockout cell lines using short hairpin RNA (shRNA) and CRISPR-Cas9 technologies. The first protocol involved cloning of a shRNA cassette targeted to human pyruvate carboxyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a145a0614db3414290910f3ff4804d
https://doi.org/10.1007/978-1-4939-8994-2_26
https://doi.org/10.1007/978-1-4939-8994-2_26
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:1023-1026
Cervical cancer is the most important female gynecological cancer, the second leading cause of cancer mortality in women worldwide and the second most common cancer in Thai women. The major cause of cervical cancer is persistent infection of human pa
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(3)
Vulva and Vaginal cancers are rare among all gynecological cancers worldwide, including Thailand, and typically affect women in later life. Persistent high risk human papillomavirus (HR-HPV) infection is one of several important causes of cancer deve
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 78
Background HPV serology is important for studies of vaccine immunogenicity, but can not be performed in a comparable manner without international standardisation. Objectives To find suitable candidate sera from naturally infected persons for use as I